EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum metabolomics modelling reveals stage-associated purine and endocannabinoid metabolic signatures in colorectal cancer progression

Jakub Klekowski, Paulina Fortuna, Mariusz Chabowski, Łukasz Lewandowski, Wioleta Szewczak, Karolina Mosna, Gabriela Maciejewska, Marek Zawadzki, Małgorzata Krzystek-Korpacka, Mariusz Fleszar

Frontiers in Oncology · 05.08.2026 · 16

DOI: 10.3389/fonc.2026.1900337 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 05.08.2026. Verfasst von Jakub Klekowski und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, 4th Military Clinical Hospital, Wroclaw, Poland. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Colorectal cancer (CRC) remains one of the major challenges in contemporary oncology. Despite advances in imaging diagnostics and histopathological assessment, we still lack tools for the early detection of micrometastases and molecular alterations. The purinergic and endocannabinoid systems play an important role in CRC pathogenesis, yet their mutual interactions are not fully understood.

Methods

The study involved serum samples from 117 patients undergoing CRC surgical treatment. We performed targeted serum metabolomic profiling of purine metabolites and endocannabinoid-related lipids. Advanced statistical modeling (elastic-net regression and stepwise selection) was applied to link metabolite concentrations with TNM stage and pathological features, such as neuroinvasion and vascular infiltration.

Results

AMP was the strongest marker positively correlated with higher TNM stage. On the other hand, 2-AG level showed consistent negative correlation with neuroinvasion and lymphatic nodes metastasis. Xanthine level and N stage correlation was also observed.

Conclusions

The results allow us to propose a model in which AMP and 2-AG constitute opposing poles of the metabolic profile in CRC patients An increase in serum AMP was associated with more advanced CRC stage, whereas lower 2-AG levels were associated with invasive features, particularly neuroinvasion. This suggests that altered purine/nucleotide metabolism may be associated with reduced endocannabinoid tone in advanced CRC. However, the proposed interaction between purinergic signalling, COX-2 activity and 2-AG metabolism should be interpreted as a hypothesis-generating model requiring direct tissue-level validation. These findings support further investigation of purine–endocannabinoid crosstalk as a potential biologically relevant pathway in CRC progression, but therapeutic implications require direct tissue-level and functional validation.

Schlagwörter

Stichwörter der Autor:innen

colorectal cancerendocannabinoid systempurine metabolismserum metabolomicstumor progression

Autor:innen und Institutionen

  • Department of Surgery, 4th Military Clinical Hospital, Wroclaw, Poland.
  • Division of Anesthetic and Surgical Nursing, Department of Nursing, Faculty of Nursing and Midwifery, Wroclaw Medical University, Wroclaw, Poland.
  • Omics Research Center, Wroclaw Medical University, Wroclaw, Poland.
  • Department of Clinical Surgical Sciences, Faculty of Medicine, Wroclaw University of Science and Technology, Wroclaw, Poland.
  • Department of Biochemistry and Immunochemistry, Wroclaw Medical University, Wroclaw, Poland.
  • Department of Oncological Surgery, Research and Development Centre at Regional Specialist Hospital, Wroclaw, Poland.

Zitieren

APA

Klekowski, J., Fortuna, P., Chabowski, M., Lewandowski, Ł., Szewczak, W., Mosna, K., Maciejewska, G., Zawadzki, M., Krzystek-Korpacka, M., & Fleszar, M. (2026). Serum metabolomics modelling reveals stage-associated purine and endocannabinoid metabolic signatures in colorectal cancer progression. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1900337

Vancouver

Klekowski J, Fortuna P, Chabowski M, Lewandowski Ł, Szewczak W, Mosna K, et al. Serum metabolomics modelling reveals stage-associated purine and endocannabinoid metabolic signatures in colorectal cancer progression. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1900337

BibTeX
@article{Klekowski2026,
  author = {Klekowski, Jakub and Fortuna, Paulina and Chabowski, Mariusz and Lewandowski, Łukasz and Szewczak, Wioleta and Mosna, Karolina and Maciejewska, Gabriela and Zawadzki, Marek and Krzystek-Korpacka, Małgorzata and Fleszar, Mariusz},
  title = {Serum metabolomics modelling reveals stage-associated purine and endocannabinoid metabolic signatures in colorectal cancer progression},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1900337}
}
Kostenlos starten →